| Name | Capital Medical |
|---|---|
| Organization Name | Helget Inc |
| Location | 145 S 66th St, Lincoln, Nebraska 68510 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (402) 484-7373 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment - a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy - triggers anti-tumor immune responses in these type of patients.
The international humanitarian organization Medecins Sans Frontières has witnessed a dramatic increase in the number of patients with the parasitic disease visceral leishmaniasis ("kala azar") admitted to its treatment center in Somalia.
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
› Verified 9 days ago
| NPI Number | 1457330326 |
| Organization Name | HELGET INC |
| Doing Business As | CAPITAL MEDICAL |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6891 A St Ste 118, Lincoln, NE 68510 |
| Phone Number | 402-484-7373 |
News Archive
A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment - a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy - triggers anti-tumor immune responses in these type of patients.
The international humanitarian organization Medecins Sans Frontières has witnessed a dramatic increase in the number of patients with the parasitic disease visceral leishmaniasis ("kala azar") admitted to its treatment center in Somalia.
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
› Verified 9 days ago
News Archive
A new study reveals that people are sharing images of their genitalia on social media in the hope of getting their sexually transmitted infections (STIs) diagnosed by others. This disturbing news not only points at rise in STIs but also misconceptions and lack of motivation to seek authentic medical advice say researchers. The study was published this week in the latest issue of the Journal of American Medical Association (JAMA).
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine show that a two-step personalized immunotherapy treatment - a dendritic cell vaccine using patients' own tumor followed by adoptive T cell therapy - triggers anti-tumor immune responses in these type of patients.
The international humanitarian organization Medecins Sans Frontières has witnessed a dramatic increase in the number of patients with the parasitic disease visceral leishmaniasis ("kala azar") admitted to its treatment center in Somalia.
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
Agendia, a world leader in molecular cancer diagnostics, today announced the inauguration of a new state-of-the-art clinical genomics laboratory in Irvine, CA. Previously, Agendia's offices and laboratory were located in Huntington Beach, CA. The new laboratory will further increase capacity to support Agendia's strong commercial expansion in the U.S. market, as well as the use of multiple Agendia tests in clinical research. MammaPrint, the company's lead product and the only FDA-cleared breast cancer recurrence test, is reimbursed by an increasing number of payers, covering some 100 million lives today.
› Verified 9 days ago
Able Ii Prosthetics And Orthotics Type: Medicare Supplier Location: 2222 S 16th St, Lincoln, Nebraska 68502 Phone: (402) 483-8898 | |
Acs Medical Llc Type: DME Supplier - Oxygen Equipment & Supplies Location: 233 N 48th St, Lincoln, Nebraska 68504 Phone: (402) 467-1014 | |
Ahp-mhr Homecare Llp Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1801 Cushman Dr, Lincoln, Nebraska 68512 Phone: (402) 420-7744 | |
Russ's Pharmacy #1 Type: Community/Retail Pharmacy Location: 1709 Washington St, Lincoln, Nebraska 68502 Phone: (402) 474-2102 | |
Russ's Pharmacy #21 Type: Community/Retail Pharmacy Location: 1550 S Coddington Ave, Lincoln, Nebraska 68522 Phone: (402) 435-8241 |